Showing results (1051-1060 of 20,012) with videos related to

Sort By:
Pageof 2,002
International Journal of Radiation Oncology, Biology, Physics|June 9, 2012
Mean absorbed dose to the anal-sphincter region and fecal leakage among irradiated prostate cancer survivorsDavid Alsadius, Maria Hedelin, Dan Lundstedt, et al.
International Journal of Radiation Oncology, Biology, Physics|May 8, 2012
Evaluation of tumor shape variability in head-and-neck cancer patients over the course of radiation therapy using implanted gold markersOlga Hamming-Vrieze, Simon Robert van Kranen, Suzanne van Beek, et al.
International Journal of Radiation Oncology, Biology, Physics|May 8, 2012
Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing lossRune Rasmussen, Magnus Claesson, Sven-Eric Stangerup, et al.
International Journal of Radiation Oncology, Biology, Physics|May 8, 2012
Cosmetic outcome and seroma formation after breast-conserving surgery with intraoperative radiation therapy boost for early breast cancerSashendra Senthi, Emma Link, Boon H Chua
International Journal of Radiation Oncology, Biology, Physics|May 8, 2012
The abscopal effect associated with a systemic anti-melanoma immune responseEmily F Stamell, Jedd D Wolchok, Sacha Gnjatic, et al.
International Journal of Radiation Oncology, Biology, Physics|May 16, 2012
Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapyMohsen Bakhshandeh, Bijan Hashemi, Seied Rabi Mehdi Mahdavi, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2012
Risk of radiation retinopathy in patients with orbital and ocular lymphomaMegha Kaushik, Jose S Pulido, Steven E Schild, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2012
Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignanciesYun Liang, Mark Bydder, Catheryn M Yashar, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2012
A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomasRobert B Den, Mitchell Kamrava, Zhi Sheng, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2002
Sarcoma as a second malignancy after treatment for breast cancerJohnny Yap, Paul J Chuba, Ron Thomas, et al.
Pageof 2,002